AñadirLa Nacióncomo fuente preferida en

Interés Humano

Brasil anuncia acuerdo para producir vacuna británica contra coronavirus

El país suramericano tendrá derecho a producir 70 millones de dosis adicionales, a un costo estimado de $2,30 cada una

(FILES) In this file photo taken on March 26, 2020 a researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - Brazil said on June 27, 2020 it had reached a deal to produce up to 100 million doses of the coronavirus vaccine being developed by Oxford University, which the country is helping to test. The vaccine, which Oxford is working on with pharmaceuticals group AstraZeneca, is one of the most promising of the dozens that researchers worldwide are racing to test and bring to market. (Photo by Douglas MAGNO / AFP)
(FILES) In this file photo taken on March 26, 2020 a researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - Brazil said on June 27, 2020 it had reached a deal to produce up to 100 million doses of the coronavirus vaccine being developed by Oxford University, which the country is helping to test. The vaccine, which Oxford is working on with pharmaceuticals group AstraZeneca, is one of the most promising of the dozens that researchers worldwide are racing to test and bring to market. (Photo by Douglas MAGNO / AFP) DOUGLAS MAGNO
AFP
Un investigador trabajaba en Belo Horizonte, Brasil, en replicar un virus como parte de los trabajos para desarrollar una vacuna contra la covid-19. AFP Un investigador trabajaba en Belo Horizonte, Brasil, en replicar un virus como parte de los trabajos para desarrollar una vacuna contra la covid-19. (DOUGLAS MAGNO/AFP)

Brasilia. Brasil anunció el sábado que llegó a un acuerdo para producir hasta 100 millones de dosis de la vacuna contra el coronavirus desarrollada por la universidad británica de Oxford, que el país suramericano está ayudando a probar.

La vacuna, en la que Oxford trabaja junto al grupo farmacéutico AstraZeneca, figura entre las más prometedoras de las decenas que están experimentando investigadores de todo el mundo.

‌
‌

‌

‌
‌

‌

‌